Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro's UK private price changed significantly from September 2025, when Eli Lilly raised its list price at the higher doses. Before that date, the top-dose pen cost roughly £122; after, reported prices for the same strength rose to around £330 per four-week pen, with providers typically charging somewhere between £149 and £375 a month depending on the dose and the service included. These are prescription-only medicines — a prescriber has to assess whether Mounjaro is clinically suitable for you before any treatment can be dispensed. How a provider prices that prescription, and what it actually covers, varies more than most people expect.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Eli Lilly announced a list-price increase for Mounjaro in the UK, effective 1 September 2025. The change was most dramatic at higher doses: the highest-strength pen moved from a list price of around £122 to roughly £330, a figure widely reported across UK health and consumer press at the time. Lower doses saw smaller increases, which is why the 5mg pen sits at a different price point to what you pay as your prescriber titrates your dose upward through treatment.
Private providers set their own prices on top of that list cost, so what you see quoted on a pharmacy website reflects both Lilly's wholesale price and whatever margin, overhead and service infrastructure the provider has built in. That's why quoted prices across providers vary considerably at identical dose levels, and why comparing on price alone doesn't tell the full story. Our guide to Mounjaro costs in the UK breaks down what drives those differences.
One thing worth knowing: Mounjaro, the brand name for tirzepatide, is a Black Triangle medicine, meaning it carries additional MHRA monitoring requirements. Eli Lilly is an authorised UK supplier; treatment dispensed through the licensed UK supply chain is subject to that scrutiny. It's one of the structural costs embedded in a legitimate private prescription.
A price quoted in bold on a website often covers the medicine itself and little else. Consultation fees, prescription charges, delivery costs and aftercare can all be billed separately, and with some providers, they are. A prescription issued without any follow-up clinical review isn't cost-effective if you later pay separately for dose-adjustment advice or hit a problem and have no one to call.
At nume, every treatment order includes a free consultation, the prescription, free tracked next-working-day delivery and seven-day aftercare access. No repeat order goes out without a fresh clinical assessment. You can see the full breakdown of what the pen price at each dose covers on our treatment detail page.
Some people assume the consultation is a formality, a box to tick before the medicine ships. It isn't. Under NICE guidance TA1026 on tirzepatide, treatment should be reviewed at six months to assess clinical response; at nume, that review is built into the process rather than sold as an optional extra.
Occasionally a low price reflects a genuinely lean operation. More often, when a price sits well below the market range, it signals one of three things: the consultation or prescription is charged separately; the service has stripped out aftercare; or the medicine isn't coming through the licensed UK supply chain at all.
The MHRA has warned publicly about fake weight-loss pens sold online and via social media. In October 2025, enforcement teams raided a site in Northampton that had been manufacturing counterfeit tirzepatide pens, the same active ingredient as Mounjaro. Approximately 20 million doses of illegally traded weight-loss medicines, valued at roughly £45 million, were seized across 2025. Some counterfeit pens have contained insulin instead of the stated medicine. You can verify any online pharmacy on the GPhC register (our registration number is 9012878) and the MHRA invites anyone who encounters a suspect seller to report it at yellowcard.mhra.gov.uk.
Price is genuinely the wrong test for a prescription medicine. What keeps you safe is a verifiable supply chain, a real clinician reviewing your case, and a pharmacy that answers the phone when something goes wrong.
Directly: we are not the cheapest provider, and that's a deliberate decision. Consultation, prescription, delivery and ongoing clinical aftercare all cost something to run properly, and we'd rather include them in one transparent figure than strip them out to win a price comparison. Current treatment pricing is shown on our weight-loss treatments page.
What the transparent price buys is a prescriber who reads your consultation the same day (a named clinician, not software) identity and weight verified by video, and a pen dispatched by DPD in plain, unbranded packaging the same afternoon if you order before noon. Every repeat requires fresh clinical sign-off; there are no auto-renewals. If you want to understand what nume is as a service before you start, our about page sets it out without the marketing language.
For context on how costs compare across the dose schedule, our overview of Mounjaro pen prices by dose explains how the monthly figure changes as treatment progresses. And if you're thinking ahead to what happens once you reach a healthy weight, the clinical picture at that stage is worth reading before you start.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.